TY - JOUR
T1 - Physical activity and/or sedentary behaviour and the development of functional disability in community-dwelling older adults in Tsuru, Japan
T2 - A prospective cohort study (the Tsuru Longitudinal Study)
AU - Sato, Shinichiro
AU - Takeda, Noriko
AU - Yamada, Takuya
AU - Nakamura, Mutsumi
AU - Nemoto, Yuta
AU - Maruo, Kazushi
AU - Fukuda, Yoshiharu
AU - Sawada, Susumu S.
AU - Kitabatake, Yoshinori
AU - Arao, Takashi
N1 - Funding Information:
Funding This study was supported by Grant-in-Aid for Scientific Research B of the Japan Society for the Promotion of Science Grant Number 15H03089 and a research grant from the Japanese Physical Therapy Association for large-scale clinical research Grant Number (29-310). These funders were not involved in study design, data collection, data analysis and manuscript preparation.
Publisher Copyright:
©
PY - 2022/3/21
Y1 - 2022/3/21
N2 - Objectives To clarify the association between moderate-to-vigorous physical activity (MVPA) and/or sedentary behaviour (SB) and the incidence of functional disability (FD) in older adults. Design Prospective cohort study. Setting Local municipality of Tsuru, Yamanashi, Japan. We conducted a baseline survey in January 2016. Follow-up was commenced on 1 February 2016 and completed on 31 October 2018. Participants All individuals (6661 people) aged >65 years who were independently living in the community were eligible. Methods and outcome measures MVPA (min/week) and SB (min/day) were measured using self-administered questionnaires in 5311 independently living older adults who participated in this study. The follow-up period was 33 months, and the incidence of FD was objectively determined by experts. The participants were divided into three groups based on MVPA distribution (non-MVPA, 0 min; short-MVPA, 1-299 min and long-MVPA, ≥300 min/week) and into two groups based on the median value of SB (short-SB,<190 min; and long-SB, ≥190 min/day). The participants were also classified into six categories based on different combinations of MVPA and SB. Cox proportional hazards model was used to calculate the HR and 95% CI for FD development with MVPA, SB and a combination of these behaviours. Results Among the included participants, 2415 were male and 2896 were female. The mean ages (SD) of the male and female participants were 74.5 (6.8) and 74.9 (6.9) years, respectively. The total number of participants with chronic conditions was 3489 (65.7%). Using the non-MVPA group as the reference, the multivariable-adjusted HR (95% CI) was 0.68 (0.54 to 0.84) in the short-MVPA group and 0.53 (0.41 to 0.69) in the long-MVPA group. Regarding SB, the short-SB group had an HR of 0.86 (0.71 to 1.03) compared with the long-SB group. The combined behaviour showed the lowest HR in the long-MVPA and short-SB group 0.49 (0.34 to 0.72) and the long-MVPA and long-SB group 0.49 (0.34 to 0.68), respectively. Conclusions Long-MVPA had a robust association with FD development, whereas short-SB had a modest association. Moreover, a combination of these behaviours had a stronger association than individual behaviours. If the identified associations are assumed to be causal in nature, these findings suggest that encouraging older adults to engage in MVPA and reduce SB in their daily lives could be effective to prevent or delay FD development.
AB - Objectives To clarify the association between moderate-to-vigorous physical activity (MVPA) and/or sedentary behaviour (SB) and the incidence of functional disability (FD) in older adults. Design Prospective cohort study. Setting Local municipality of Tsuru, Yamanashi, Japan. We conducted a baseline survey in January 2016. Follow-up was commenced on 1 February 2016 and completed on 31 October 2018. Participants All individuals (6661 people) aged >65 years who were independently living in the community were eligible. Methods and outcome measures MVPA (min/week) and SB (min/day) were measured using self-administered questionnaires in 5311 independently living older adults who participated in this study. The follow-up period was 33 months, and the incidence of FD was objectively determined by experts. The participants were divided into three groups based on MVPA distribution (non-MVPA, 0 min; short-MVPA, 1-299 min and long-MVPA, ≥300 min/week) and into two groups based on the median value of SB (short-SB,<190 min; and long-SB, ≥190 min/day). The participants were also classified into six categories based on different combinations of MVPA and SB. Cox proportional hazards model was used to calculate the HR and 95% CI for FD development with MVPA, SB and a combination of these behaviours. Results Among the included participants, 2415 were male and 2896 were female. The mean ages (SD) of the male and female participants were 74.5 (6.8) and 74.9 (6.9) years, respectively. The total number of participants with chronic conditions was 3489 (65.7%). Using the non-MVPA group as the reference, the multivariable-adjusted HR (95% CI) was 0.68 (0.54 to 0.84) in the short-MVPA group and 0.53 (0.41 to 0.69) in the long-MVPA group. Regarding SB, the short-SB group had an HR of 0.86 (0.71 to 1.03) compared with the long-SB group. The combined behaviour showed the lowest HR in the long-MVPA and short-SB group 0.49 (0.34 to 0.72) and the long-MVPA and long-SB group 0.49 (0.34 to 0.68), respectively. Conclusions Long-MVPA had a robust association with FD development, whereas short-SB had a modest association. Moreover, a combination of these behaviours had a stronger association than individual behaviours. If the identified associations are assumed to be causal in nature, these findings suggest that encouraging older adults to engage in MVPA and reduce SB in their daily lives could be effective to prevent or delay FD development.
KW - Epidemiology
KW - Geriatric medicine
KW - Preventive medicine
KW - Public health
UR - http://www.scopus.com/inward/record.url?scp=85126861817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126861817&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2021-056642
DO - 10.1136/bmjopen-2021-056642
M3 - Article
C2 - 35314473
AN - SCOPUS:85126861817
SN - 2044-6055
VL - 12
JO - BMJ open
JF - BMJ open
IS - 3
M1 - e056642
ER -